NCT02013141 - Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

Gram-Positive Bacterial Infections

Interventions

DRUG

Telavancin

Trial Locations (7)

Toledo Children's Hospital, Toledo

Rainbow Babies and Children's Hospital, Cleveland

Children's Mercy Hospital, Kansas City

Arkansas Children's Hospital, Little Rock

Rady Children's Hospital San Diego, San Diego

Children's Hospital of Orange County, Orange

Rutgers-Robert Wood Johnson Medical School, New Brunswick